Arias JJ, Manchester M, Lah J. Direct to Consumer Biomarker Testing for Alzheimer Disease-Are We Ready for the Insurance Consequences?. JAMA Neurol. 2024 Feb 1;81(2):107-108. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.